{{Rsnum
|rsid=2273206
|Gene=ESR1
|Chromosome=6
|position=152061176
|Orientation=plus
|GMAF=0.2365
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=ESR1
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 85.8 | 13.3 | 0.9
| HCB | 46.0 | 41.6 | 12.4
| JPT | 52.2 | 42.5 | 5.3
| YRI | 23.8 | 44.2 | 32.0
| ASW | 40.4 | 47.4 | 12.3
| CHB | 46.0 | 41.6 | 12.4
| CHD | 39.8 | 43.5 | 16.7
| GIH | 62.4 | 33.7 | 4.0
| LWK | 38.2 | 43.6 | 18.2
| MEX | 91.4 | 8.6 | 0.0
| MKK | 34.0 | 50.6 | 15.4
| TSI | 82.2 | 15.8 | 2.0
| HapMapRevision=28
}}

{{PMID|18424448|OA=1
}} haplotype less common in [[schizophrenia]] [[rs2273206]](T), [[rs2273207]](G), [[rs2228480]](G).

{{ neighbor
| rsid = 2273207
| distance = 14
}}

{{PMID Auto
|PMID=19654868
|Title=Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer
|OA=1
}}

{{PMID Auto
|PMID=18305958
|Title=Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}